In this example, we are going to reproduce the pre-trained model DDLS.colon.lee available at the digitalDLSorteRmodels R package. It was trained on data from Lee et al. (2020) (GSE132465, GSE132257 and GSE144735), and consist of ~ 100,000 cells from a total of 31 patients including tumoral and healthy samples. These cells are divided into 22 cell types covering the main ones found in this kind of samples: Anti-inflammatory_MFs (macrophages), B cells, CD4+ T cells, CD8+ T cells, ECs (endothelial cells), ECs_tumor, Enterocytes, Epithelial cells, Epithelial_cancer_cells, MFs_SPP1+, Mast cells, Myofibroblasts, NK cells, Pericytes, Plasma_cells, Pro-inflammatory_MFs, Regulatory T cells, Smooth muscle cells, Stromal cells, T follicular helper cells, cDC (conventional dendritic cells), and gamma delta T cells. The expression matrix only contains 2,000 genes selected by digitalDLSorteR when the model was created to save time and RAM. Thus, in this example we will set the parameters related to gene filtering to zero.

Loading data

We are also going to load bulk RNA-seq data on colorectal cancer patients from the The Cancer Genome Atlas (TCGA) program (Koboldt et al. 2012; Ciriello et al. 2015). When building new deconvolution models, we recommend loading both the single-cell RNA-seq reference and the bulk RNA-seq dataset to be deconvoluted at the beginning so that digitalDLSorteR can choose only genes actually relevant for the deconvolution process.

data("SCE.colon.Lee")
data("TCGA.colon.se")
# to make it suitable for digitalDLSorteR
rowData(TCGA.colon.se) <- DataFrame(SYMBOL = rownames(TCGA.colon.se))

Note: Please, note that here sc.filt.genes.cluster = FALSE and sc.log.FC = FALSE because we are providing with data already preprocessed. However, we recommend keeping sc.filt.genes.cluster = TRUE and sc.log.FC = TRUE in regular situations, as digitalDLSorteR will filter genes according to their logFC.

DDLS.colon <- createDDLSobject(
  sc.data = SCE.colon.Lee,
  sc.cell.ID.column = "Index",
  sc.gene.ID.column = "SYMBOL",
  sc.cell.type.column = "Cell_type_6",
  bulk.data = TCGA.colon.se,
  bulk.sample.ID.column = "Bulk",
  bulk.gene.ID.column <- "SYMBOL",
  filter.mt.genes = "^MT-",
  sc.filt.genes.cluster = FALSE,
  sc.log.FC = FALSE,
  sc.min.counts = 0,
  sc.min.cells = 0,
  verbose = TRUE, 
  project = "Colon-Cancer-Project"  
)
## === Processing bulk transcriptomics data
##       - Removing 2568 genes without expression in any cell
## 'as(<dgCMatrix>, "dgTMatrix")' is deprecated.
## Use 'as(., "TsparseMatrix")' instead.
## See help("Deprecated") and help("Matrix-deprecated").
##       - Filtering features:
##          - Selected features: 54918
##          - Discarded features: 1599
## 
## === Processing single-cell data
##       - Filtering features:
##          - Selected features: 2000
##          - Discarded features: 0
## 
## === No mitochondrial genes were found by using ^MT- as regrex
## 
## === Final number of dimensions for further analyses: 2000

After loading the data, we have a DigitalDLSorter object with 2,000 genes and both the single-cell RNA-seq used as reference and the bulk RNA-seq data to be deconvoluted.

DDLS.colon
## An object of class DigitalDLSorter 
## Real single-cell profiles:
##   2000 features and 106364 cells
##   rownames: ADAMTS15 LY6G5B FBXO17 ... FBXO17 HLA-DPA1 ACKR3 CORIN 
##   colnames: SMC01-T_GGACAAGAGCTGGAAC SMC03-T_GCAAACTCAGCGATCC SMC05-N_TACTCATCAGATGAGC ... SMC05-N_TACTCATCAGATGAGC SMC06-T_TCTCTAAAGATCACGG SMC171-N-SING_GTATCTTAGTGGTAGC SMC13T-A1-F_CATTCGCGTCATGCAT 
## Bulk samples to deconvolute:
##   Bulk.DT bulk samples:
##     2000 features and 521 samples
##     rownames: LINC00582 ACE2 MAL ... MAL MAGEA11 FZD10 COMP 
##     colnames: e79dd77e.6b51.4b49.ae8c.379c55ddae21 X9df77d76.ce4c.452d.9ce3.c0e1dc2360b8 X24c0b854.79c3.436a.87a7.4d0bbfac626a ... X24c0b854.79c3.436a.87a7.4d0bbfac626a dc4bba2d.8d49.4dcc.aa3c.17688fe73479 X8d445b92.e331.421c.9de0.d55a2fee908d X789c1767.4073.4ffa.b193.54b20b96d55e 
## Project: Colon-Cancer-Project

Generating cell composition matrix

Now, let’s generate the cell composition matrix by using the generateBulkCellMatrix function. It requires a data frame with prior knowledge about how likely is to find each cell type in a sample. For this example, we have used an approximation based on the frequency of each cell type in each patient/sample from the scRNA-seq dataset:

prop.design <- single.cell.real(DDLS.colon)@colData %>% as.data.frame() %>% 
  group_by(Patient, Cell_type_6) %>% summarize(Total = n()) %>% 
  mutate(Prop = (Total / sum(Total)) * 100) %>% group_by(Cell_type_6) %>% 
  summarise(Prop_Mean = ceiling(mean(Prop)), Prop_SD = ceiling(sd(Prop))) %>% 
  mutate(
    from = Prop_Mean, 
    to.1 = Prop_Mean * (Prop_SD * 2),
    to = ifelse(to.1 > 100, 100, to.1),
    to.1 = NULL, Prop_Mean = NULL, Prop_SD = NULL
  )
## `summarise()` has grouped output by 'Patient'. You can override using the
## `.groups` argument.

Then, we can generate the actual pseudobulk samples that will follow these cell proportions. In this case, we generate 10,000 pseudobulk samples (num.bulk.samples), although this number could be increased according to available computational resources.

## for reproducibility
set.seed(123)
DDLS.colon <- generateBulkCellMatrix(
  object = DDLS.colon,
  cell.ID.column = "Index",
  cell.type.column = "Cell_type_6",
  prob.design = prop.design,
  num.bulk.samples = 10000,
  verbose = TRUE
) %>% simBulkProfiles(threads = 2)
## 
## === The number of bulk RNA-Seq samples that will be generated is equal to 10000
## 
## === Training set cells by type:
##     - Anti-inflammatory_MFs: 501
##     - B cells: 7336
##     - CD4+ T cells: 10595
##     - CD8+ T cells: 7570
##     - cDC: 481
##     - ECs: 874
##     - ECs_tumor: 1398
##     - Enterocytes: 920
##     - Epithelial cells: 1411
##     - Epithelial_cancer_cells: 19447
##     - gamma delta T cells: 1459
##     - Mast cells: 499
##     - MFs_SPP1+: 4118
##     - Myofibroblasts: 1789
##     - NK cells: 1056
##     - Pericytes: 677
##     - Plasma_cells: 6259
##     - Pro-inflammatory_MFs: 2342
##     - Regulatory T cells: 4233
##     - Smooth muscle cells: 614
##     - Stromal cells: 5555
##     - T follicular helper cells: 639
## === Test set cells by type:
##     - Anti-inflammatory_MFs: 155
##     - B cells: 2456
##     - CD4+ T cells: 3515
##     - CD8+ T cells: 2583
##     - cDC: 163
##     - ECs: 336
##     - ECs_tumor: 431
##     - Enterocytes: 347
##     - Epithelial cells: 439
##     - Epithelial_cancer_cells: 6400
##     - gamma delta T cells: 499
##     - Mast cells: 175
##     - MFs_SPP1+: 1406
##     - Myofibroblasts: 592
##     - NK cells: 325
##     - Pericytes: 206
##     - Plasma_cells: 2075
##     - Pro-inflammatory_MFs: 761
##     - Regulatory T cells: 1467
##     - Smooth muscle cells: 191
##     - Stromal cells: 1829
##     - T follicular helper cells: 240
## === Probability matrix for training data:
##     - Bulk RNA-Seq samples: 7500
##     - Cell types: 22
## === Probability matrix for test data:
##     - Bulk RNA-Seq samples: 2500
##     - Cell types: 22
## DONE
## === Setting parallel environment to 2 thread(s)
## 
## === Generating train bulk samples:
## 
## === Generating test bulk samples:
## 
## DONE

Neural network training

After generating the pseudobulk samples, we can train and evaluate the model. The training step is only performed using cells/pseudobulk samples coming from the training subset, since the test subset will be used for the assessment of its performance.

DDLS.colon <- trainDDLSModel(object = DDLS.colon, verbose = FALSE)
##  1/79 [..............................] - ETA: 9s - loss: 0.1178 - accuracy: 0.7812 - mean_absolute_error: 0.0116 - categorical_accuracy: 0.781255/79 [===================>..........] - ETA: 0s - loss: 0.1234 - accuracy: 0.6938 - mean_absolute_error: 0.0135 - categorical_accuracy: 0.693879/79 [==============================] - 0s 935us/step - loss: 0.1232 - accuracy: 0.6960 - mean_absolute_error: 0.0135 - categorical_accuracy: 0.6960

Evaluation of the model on test data

Once the model is trained, we can explore how well the model behaves on test samples. This step is critical because it allows us to assess if digitalDLSorteR is actually understanding the signals coming from each cell type or if on the contrary there are cell types being ignored.

DDLS.colon <- calculateEvalMetrics(object = DDLS.colon)

digitalDLSorteR implements different functions to visualize the results and explore potential biases on the models. For this tutorial, we will check the correlation between expected and predicted proportions, but for a more detailed explanation about other visualization functions, check the Documentation.

corrExpPredPlot(
  DDLS.colon,
  color.by = "CellType",
  facet.by = "CellType",
  corr = "both", 
  size.point = 0.5
)
## `geom_smooth()` using formula = 'y ~ x'

As it can be seen, the model is accurately predicting the cell proportions of pseudobulk samples from the test data, which means that it is detecting differential signals for each cell type.

Deconvolution of TCGA samples

Now, to show its performance on real data, we are going to deconvolute the samples from the TCGA project (Koboldt et al. 2012; Ciriello et al. 2015) loaded at the beginning of the vignette. This dataset consists of 521 samples and includes both tumoral and healthy samples. This step is performed by the deconvDDLSObj function, which will use the trained model to obtain a set of predicted proportions for each sample contained in the deconv.data slot.

DDLS.colon <- deconvDDLSObj(object = DDLS.colon, verbose = FALSE)
##    No 'name.data' provided. Using the first dataset

We can plot the results as follows:

barPlotCellTypes(DDLS.colon, rm.x.text = TRUE)
## 'name.data' not provided. By default, first results are used

As the total number of samples is too high, we can see the results of some samples by taking the predicted cell proportions and plotting 20 random samples with barPlotCellTypes:

set.seed(12345)
resDeconvTCGA <- deconv.results(DDLS.colon, name.data = "Bulk.DT")
barPlotCellTypes(
  resDeconvTCGA[sample(1:521, size = 20), ], rm.x.text = TRUE,
  title = "Results of deconvolution (20 random samples)"
)

Now, we can represent the cell proportions of every cell type considered by the model separating healthy and tumoral samples. We are also going to filter out samples considered metastatic or recurrent (check the TCGA.colon.se object) because these groups are composed of only 1 sample:

data.frame(
  Sample = rownames(resDeconvTCGA),
  TypeSample = colData(TCGA.colon.se)[["Tumor_Type"]]
) %>% cbind(resDeconvTCGA) %>% 
  reshape2::melt() %>% filter(!TypeSample %in% c("Metastatic", "Recurrent")) %>% 
  ggplot(aes(x = TypeSample, y = value, fill = variable)) + 
  geom_boxplot() + facet_wrap(~ variable, scales = "free") + 
  scale_fill_manual(values = digitalDLSorteR:::default.colors()) + 
  ggtitle("Estimated proportions in TCGA data (all cell types)") + theme_bw() + 
    theme(
      plot.title = element_text(face = "bold", hjust = 0.5),
      legend.title = element_text(face = "bold")
    )
## Using Sample, TypeSample as id variables

In general, the results seem to be in line with what it is known: tumoral samples show a huge immune infiltration, whereas other cell types such as epithelial cells are displaced. We can also specifically inspect the predicted proportions of enterocytes, tumor, epithelial, and stromal cells:

data.frame(
  Sample = rownames(resDeconvTCGA),
  CRC = resDeconvTCGA[, "Epithelial_cancer_cells"],
  Epithelial = resDeconvTCGA[, "Epithelial cells"],
  Stromal = resDeconvTCGA[, "Stromal cells"],
  Entero = resDeconvTCGA[, "Enterocytes"],
  TypeSample = TCGA.colon.se@colData$Tumor_Type
) %>% filter(!TypeSample %in% c("Metastatic", "Recurrent")) %>% 
  reshape2::melt() %>% 
  ggplot(aes(x = TypeSample, y = value, fill = TypeSample)) +
    geom_boxplot() + facet_wrap(~ variable) + ylab("Estimated proportion") + 
  scale_fill_manual(values = digitalDLSorteR:::default.colors()) + 
    ggtitle("Estimated proportions in TCGA data") + theme_bw() + 
    theme(
      plot.title = element_text(face = "bold", hjust = 0.5),
      legend.title = element_text(face = "bold")
    )
## Using Sample, TypeSample as id variables

As it can be seen, digitalDLSorteR correctly estimates the absence of tumor cells (CRC) in healthy samples. On the other hand, the predicted proportion of enterocytes, epithelial and stromal cells decrease in the tumoral samples, which makes sense considering the infiltration of immune cells and the increased presence of tumoral cells.

Interpreting the neural network model

Finally, we have implemented a way to make the predictions made by digitalDLSorteR more interpretable. This part was developed for our new R package for deconvolution of spatial transcriptomics data SpatialDDLS, and the methodology is explained in Mañanes et al. (2024).

DDLS.colon <- interGradientsDL(DDLS.colon)

We can explore the top 5 genes with the highest gradient for each cell type to check which genes are being more used by the model:

top.gradients <- topGradientsCellType(
  DDLS.colon, method = "class", top.n.genes = 5
)
sapply(
  top.gradients, \(x) x$Positive
) %>% as.data.frame()
##   Anti-inflammatory_MFs B cells CD4+ T cells CD8+ T cells   ECs ECs_tumor
## 1                 LYVE1    IGHD        KLRB1         GZMK CD320     HSPG2
## 2                  PLTP   FCRL1        ANXA1         GZMH FABP5      INSR
## 3                 FOLR2    SPIB       GPR183         CCL5 SOCS3      AQP1
## 4                LILRB5    CD19          MAL        ITM2C  CD36    FKBP1A
## 5                RNASE1    CD83      SLC4A10         GZMB   CLU     SPRY1
##   Enterocytes Epithelial cells Epithelial_cancer_cells      MFs_SPP1+
## 1     UGT2B17             ZG16                    PID1           CTSD
## 2        SPIB             AQP8                    CTSH           CD83
## 3      PCSK1N             URAD                  INSIG1          APOC1
## 4       ITM2C             TFF3                    FBN2 RP11-1008C21.1
## 5      UGT2A3            REP15                  IFITM3          MMP14
##   Mast cells Myofibroblasts NK cells Pericytes Plasma_cells
## 1       CTSG         LGALS1   FGFBP2      CD36    LINC00152
## 2      GATA2          IGFL2     CMC1 LINC00152         SRGN
## 3      TPSB2  RP11-400N13.3     GNLY    RNF152     IGHV4-61
## 4      MS4A2          MMP14    KRT86     FCGRT        IGHA1
## 5       LMNA        FAM155A    KLRC1      LHFP         RGS1
##   Pro-inflammatory_MFs Regulatory T cells Smooth muscle cells Stromal cells
## 1              S100A12               BATF               RERGL            C7
## 2                 FCN1              RTKN2               CASQ2          LSP1
## 3             SERPINB2            TNFRSF4             TSC22D1        S100A4
## 4                TIMP1               IL32                FLNA  RP3-525N10.2
## 5                 VCAN                LTB                 DES CTD-2331H12.7
##   T follicular helper cells      cDC gamma delta T cells
## 1                    CXCL13   INSIG1               KLRC2
## 2                     NR3C1 HLA-DQA2                TRDC
## 3                       NMB     CD1C               TRGC2
## 4                    PTPN13    CCL17                 CD7
## 5                      SRGN     PPA1               NR3C1

In addition, digitalDLSorteR also implements a function to plot the top gradients per cell type as a heatmap:

hh <- plotHeatmapGradsAgg(DDLS.colon, top.n.genes = 4, method = "class")
hh$Absolute

It is important to note that these markers should not be interpreted as cell type markers. Rather, they serve as indications to help interpret the model’s performance. In addition, due to the multivariate nature of this approach, gradients are surrogates at the feature level for predictions made considering all input variables collectively, and thus caution should be exercised in drawing direct conclusions about specific gene-cell type relationships.

References

Ciriello, G., M. L. Gatza, A. H. Beck, M. D. Wilkerson, S. K. Rhie, A. Pastore, H. Zhang, et al. 2015. Comprehensive molecular portraits of invasive lobular breast cancer.” Cell 163 (2): 506–19.
Koboldt, D. C., R. S. Fulton, M. D. McLellan, H. Schmidt, J. Kalicki-Veizer, J. F. McMichael, L. L. Fulton, et al. 2012. Comprehensive molecular portraits of human breast tumours.” Nature 490 (7418): 61–70.
Lee, H. O., Y. Hong, H. E. Etlioglu, Y. B. Cho, V. Pomella, B. Van den Bosch, J. Vanhecke, et al. 2020. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer.” Nat Genet 52 (6): 594–603.
Mañanes, D., I. Rivero-García, C. Relaño, Torres. M., D. Sancho, D. Jimenez-Carretero, C. Torroja, and F. Sánchez-Cabo. 2024. SpatialDDLS: an R package to deconvolute spatial transcriptomics data using neural networks.” Bioinformatics 40 (2).